GPR143

G protein-coupled receptor 143, the group of 7TM uncharacterized proteins

Basic information

Region (hg38): X:9725346-9786297

Previous symbols: [ "OA1" ]

Links

ENSG00000101850NCBI:4935OMIM:300808HGNC:20145Uniprot:P51810AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • X-linked recessive ocular albinism (Supportive), mode of inheritance: XL
  • X-linked recessive ocular albinism (Strong), mode of inheritance: XL
  • nystagmus 6, congenital, X-linked (Strong), mode of inheritance: XL
  • inherited retinal dystrophy (Definitive), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Nystagmus 6, congenital, X-linked; Ocular albinism, type IXLGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingDermatologic; Ophthalmologic7915878; 7647783; 8634705; 9887374; 9529334; 11214907; 11520764; 11793467; 17516023; 18523664; 19123159; 19390656; 19604113; 19610097; 20301517; 20649618; 21274678; 21348135; 21423867; 22916221

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GPR143 gene.

  • not provided (46 variants)
  • Ocular albinism, type I (5 variants)
  • Nystagmus 6, congenital, X-linked (3 variants)
  • GPR143-related disorder (2 variants)
  • Inborn genetic diseases (2 variants)
  • Albinism (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR143 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
51
clinvar
6
clinvar
57
missense
4
clinvar
8
clinvar
125
clinvar
5
clinvar
7
clinvar
149
nonsense
14
clinvar
14
start loss
3
clinvar
1
clinvar
4
frameshift
20
clinvar
2
clinvar
22
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
10
clinvar
10
clinvar
1
clinvar
21
splice region
2
4
8
1
15
non coding
1
clinvar
1
clinvar
24
clinvar
14
clinvar
40
Total 52 22 126 80 28

Variants in GPR143

This is a list of pathogenic ClinVar variants found in the GPR143 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-9725612-G-A Benign (May 12, 2021)1294751
X-9725758-A-C Uncertain significance (Jun 05, 2022)1438717
X-9725759-T-C Inborn genetic diseases Uncertain significance (May 30, 2024)3282221
X-9725768-A-G Benign (Jan 21, 2024)1169666
X-9725769-G-A Uncertain significance (Apr 04, 2022)1907595
X-9725772-C-A Uncertain significance (Jul 28, 2023)2798198
X-9725779-A-G Likely benign (Nov 27, 2023)1155641
X-9725790-T-C Uncertain significance (Mar 28, 2022)2118864
X-9725804-C-T Inborn genetic diseases Uncertain significance (Jun 05, 2022)2058588
X-9725805-T-C GPR143-related disorder Uncertain significance (Jul 07, 2023)2071134
X-9725806-T-G Benign (Jul 19, 2023)1166084
X-9725810-G-A Uncertain significance (Jan 28, 2021)1505115
X-9725810-G-C Uncertain significance (Oct 20, 2023)2880336
X-9725816-A-T Uncertain significance (Nov 07, 2023)2757737
X-9725822-A-G Uncertain significance (Mar 16, 2023)1475820
X-9725828-C-T Benign (Jan 02, 2024)720640
X-9725831-G-A Uncertain significance (Jul 07, 2023)3008138
X-9725844-G-C Likely benign (Jul 15, 2022)2134145
X-9739333-G-A Benign (May 12, 2021)1238273
X-9739465-T-C Likely benign (Oct 21, 2021)1578180
X-9739469-G-A not specified Benign (Jan 15, 2024)255710
X-9739470-C-A Benign (Jan 12, 2024)1165936
X-9739472-G-A Likely benign (Dec 18, 2022)3009741
X-9739474-CAG-C Likely benign (Sep 03, 2022)1940375
X-9739481-T-C not specified Benign (Jan 29, 2024)719864

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GPR143protein_codingprotein_codingENST00000467482 960952
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9250.07471256866101257020.0000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8791111400.7910.00001082562
Missense in Polyphen2651.4080.50576979
Synonymous-0.1616462.41.030.00000541853
Loss of Function3.04112.70.07888.78e-7211

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009520.000775
Ashkenazi Jewish0.000.00
East Asian0.00007240.0000544
Finnish0.000.00
European (Non-Finnish)0.00001260.00000879
Middle Eastern0.00007240.0000544
South Asian0.00005280.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for tyrosine, L-DOPA and dopamine. After binding to L-DOPA, stimulates Ca(2+) influx into the cytoplasm, increases secretion of the neurotrophic factor SERPINF1 and relocalizes beta arrestin at the plasma membrane; this ligand- dependent signaling occurs through a G(q)-mediated pathway in melanocytic cells. Its activity is mediated by G proteins which activate the phosphoinositide signaling pathway. Plays also a role as an intracellular G protein-coupled receptor involved in melanosome biogenesis, organization and transport. {ECO:0000269|PubMed:10471510, ECO:0000269|PubMed:16524428, ECO:0000269|PubMed:18697795, ECO:0000269|PubMed:18828673, ECO:0000269|PubMed:19717472}.;
Disease
DISEASE: Albinism ocular 1 (OA1) [MIM:300500]: Form of albinism affecting only the eye. Pigment of the hair and skin is normal or only slightly diluted. Eyes may be severely affected with photophobia and reduced visual acuity. Nystagmus or strabismus are often associated. The irides and fundus are depigmented. {ECO:0000269|PubMed:11115845, ECO:0000269|PubMed:11214907, ECO:0000269|PubMed:16524428, ECO:0000269|PubMed:16621890, ECO:0000269|PubMed:16646960, ECO:0000269|PubMed:17822861, ECO:0000269|PubMed:17960122, ECO:0000269|PubMed:18697795, ECO:0000269|PubMed:18978956, ECO:0000269|PubMed:8634705, ECO:0000269|PubMed:9529334, ECO:0000269|PubMed:9887374}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Nystagmus congenital X-linked 6 (NYS6) [MIM:300814]: A condition defined as conjugated, spontaneous and involuntary ocular oscillations that appear at birth or during the first three months of life. Other associated features may include mildly decreased visual acuity, strabismus, astigmatism, and occasionally head nodding. {ECO:0000269|PubMed:17516023}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
GPCRs, Other;Signaling by GPCR;Signal Transduction;Amine ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.227

Intolerance Scores

loftool
0.0848
rvis_EVS
0.02
rvis_percentile_EVS
55.45

Haploinsufficiency Scores

pHI
0.104
hipred
Y
hipred_score
0.644
ghis
0.520

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
N
gene_indispensability_score
0.231

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gpr143
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; pigmentation phenotype;

Zebrafish Information Network

Gene name
gpr143
Affected structure
retinal pigmented epithelium
Phenotype tag
abnormal
Phenotype quality
decreased pigmentation

Gene ontology

Biological process
eye pigment biosynthetic process;signal transduction;G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;visual perception;melanosome localization;melanosome transport;melanosome organization;calcium-mediated signaling using intracellular calcium source;phosphatidylinositol-mediated signaling;regulation of calcium-mediated signaling;regulation of melanosome transport;regulation of melanosome organization
Cellular component
cytoplasm;lysosomal membrane;Golgi apparatus;plasma membrane;membrane;integral component of membrane;apical plasma membrane;melanosome membrane;melanosome
Molecular function
G protein-coupled receptor activity;protein binding;dopamine binding;L-DOPA receptor activity;L-DOPA binding;tyrosine binding